Related Experiment Video

Updated: Aug 29, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Adjunctive dexamethasone treatment in acute bacterial meningitis

Abhijit Chaudhuri1

  • 1University of Glasgow, Institute of Neurological Sciences, Glasgow, UK. ac54p@udcf.gla.ac.uk

The Lancet. Neurology
|December 25, 2003
PubMed

Insights

Early antibiotic treatment for bacterial meningitis is crucial, but adding dexamethasone before or with the first dose significantly improves outcomes, especially for pneumococcal meningitis in adults and children.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Pharmacology

Background:

  • Bacterial meningitis, particularly pneumococcal meningitis, has high mortality and morbidity despite prompt antibiotic initiation.
  • Current antibiotic strategies alone are insufficient to improve patient prognosis significantly.

Purpose of the Study:

  • To evaluate the efficacy of adjuvant dexamethasone therapy in improving outcomes for patients with acute bacterial meningitis.
  • To determine the optimal timing for dexamethasone administration in conjunction with antibiotics.

Main Methods:

  • Review of randomized controlled trials and clinical evidence.
  • Analysis of treatment outcomes in patients receiving antibiotics with or without dexamethasone.
  • Stratification of results based on meningitis etiology (e.g., pneumococcal, Haemophilus) and patient demographics.

Main Results:

  • Adjunctive dexamethasone, administered before or with the first antibiotic dose, demonstrates clear benefits in reducing mortality and morbidity.
  • Unequivocal recommendation for adjuvant dexamethasone in children and adults with *Haemophilus* and pneumococcal meningitis.
  • Greatest benefit observed in otherwise healthy patients presenting early with acute bacterial meningitis.

Conclusions:

  • Dexamethasone as an adjuvant therapy represents a significant advancement in managing common bacterial meningitis.
  • Dexamethasone is not recommended for gram-negative bacillary meningitis or neonatal meningitis.
  • This practice change offers proven value in developed healthcare settings for improving patient prognosis.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...